TEX19

TEX19 is a mammalian germline and pluripotent cell protein that safeguards genome integrity by suppressing retrotransposon mobilization and regulating meiotic chromosome dynamics through modulation of UBR2 E3 ubiquitin ligase activity. TEX19.1 directly binds LINE-1-encoded ORF1p and stimulates its UBR2-dependent polyubiquitylation and proteasomal degradation, restricting L1 retrotransposition in embryonic stem cells and preventing transposable element derepression in placenta and meiotic germ cells (PMID:28806172, PMID:23364048, PMID:18802469). TEX19 paralogs also interact with PIWI proteins and directly bind piRNAs, placing them in the postnatal piRNA pathway for retrotransposon silencing (PMID:28254886). In addition to transposon defense, TEX19.1 promotes Spo11-dependent meiotic recombination in spermatocytes and maintains acetylated SMC3 cohesin on oocyte chromosome axes by inhibiting UBR2-mediated N-end rule degradation, with its loss causing chiasmata defects, chromosome missegregation, and aneuploidy transmitted to offspring (PMID:28708824, PMID:32232464).

1. 2007 Medium

   Determining where TEX19.1 protein resides revealed its nuclear localization in pluripotent cells, suggesting a nuclear function in early embryonic and germ cell biology.

   Evidence Immunofluorescence in mouse ES cells and inner cell mass

   PMID:18096721

   Open questions at the time

   • Single method (immunofluorescence) without biochemical fractionation
   • Localization in germ cells not yet examined
   • No functional data at this stage
2. 2008 High

   The first loss-of-function study established that Tex19.1 is required to repress endogenous retroviruses in the germline and to support meiotic chromosome synapsis and post-meiotic germ cell survival, linking transposon control to meiotic fidelity.

   Evidence Tex19.1 knockout mouse with histology, immunostaining for synapsis markers, RT-PCR for ERV expression

   PMID:18802469

   Open questions at the time

   • Molecular mechanism of transposon repression unknown
   • Whether synapsis defects are a direct or indirect consequence of transposon activation unclear
   • No biochemical interactors identified
3. 2009 Medium

   Identification of DAZL as a translational repressor of Tex19.1 mRNA revealed a layer of post-transcriptional control over TEX19.1 protein levels in germ cells.

   Evidence EMSA showing DAZL binding to Tex19.1 3′UTR; luciferase translation assay in zebrafish embryos

   PMID:19247806

   Open questions at the time

   • Translational repression demonstrated in heterologous system (zebrafish), not confirmed in mammalian germ cells
   • Physiological significance of DAZL-mediated Tex19.1 regulation not tested in vivo
4. 2010 High

   Discovery that TEX19.1 forms a stable complex with the E3 ubiquitin ligase UBR2 and depends on UBR2 for protein stability identified the key enzymatic partner through which TEX19.1 acts.

   Evidence Co-immunoprecipitation and western blotting in mouse testes; Ubr2 knockout showing loss of TEX19.1 protein despite normal mRNA

   PMID:21103378

   Open questions at the time

   • Substrates of the TEX19.1–UBR2 complex not yet identified
   • Whether TEX19.1 activates or redirects UBR2 catalytic activity unknown
5. 2013 High

   Extension of TEX19.1's retrotransposon-suppressive role to the placenta showed it functions outside the germline to restrain LINE-1 in hypomethylated somatic tissues, with loss causing trophoblast defects and intrauterine growth retardation.

   Evidence Tex19.1 knockout mouse placenta analysis with qPCR for retrotransposon mRNA, immunostaining for L1-ORF1p, histological quantification of trophoblast subtypes

   PMID:23364048

   Open questions at the time

   • Whether placental phenotype is entirely caused by L1 derepression or partly transposon-independent not resolved
   • Mechanism of retrotransposon suppression in placenta not defined biochemically
6. 2017 High

   Three concurrent studies resolved TEX19.1's molecular mechanism: it directly binds L1-ORF1p to stimulate UBR2-dependent polyubiquitylation and degradation of L1-ORF1p, restricting retrotransposition; it interacts with PIWI proteins and piRNAs as part of the postnatal piRNA pathway; and it promotes Spo11-dependent early meiotic recombination in a pathway genetically shared with UBR2.

   Evidence Co-IP, in vitro ubiquitylation assay, retrotransposition reporter in ESCs [PMID:28806172]; GST pulldown, mass spectrometry, Tex19 double KO [PMID:28254886]; immunostaining for RAD51/DMC1 foci, genetic epistasis with Ubr2 and Spo11 mutants [PMID:28708824]

   PMID:28254886 PMID:28708824 PMID:28806172

   Open questions at the time

   • How TEX19.1 coordinates piRNA-pathway and UBR2-dependent mechanisms is unknown
   • Whether L1-ORF1p ubiquitylation is sufficient to explain all retrotransposon suppression not tested
   • How TEX19.1–UBR2 promotes recombination foci formation mechanistically unresolved
7. 2018 High

   Demonstrating that a Spo11-dependent meiotic checkpoint delays pachytene progression in Tex19.1-null spermatocytes clarified that reduced recombination initiation triggers a surveillance mechanism rather than immediate apoptosis.

   Evidence Tex19.1 knockout and Tex19.1/Spo11 double mutant mice with immunostaining for recombination intermediates, chromatin modifications, and histone H1t staging

   PMID:29907896

   Open questions at the time

   • Identity of the checkpoint sensor detecting reduced recombination intermediates unknown
   • Whether the checkpoint is ATR/ATM-dependent not tested
8. 2020 High

   Revealing that TEX19.1 inhibits UBR2-mediated N-end rule degradation of acetylated SMC3 cohesin in oocytes uncovered a second, transposon-independent function: maintaining chromosome cohesion to prevent age-related aneuploidy.

   Evidence Tex19.1 knockout oocyte chromosome spreads showing depleted acetylated SMC3, chiasmata loss, meiosis I missegregation; co-IP of TEX19.1 with UBR2; aneuploidy transmission to offspring; UBR2 knockdown rescue in somatic cells

   PMID:32232464

   Open questions at the time

   • Whether TEX19.1 directly shields acetylated SMC3 from UBR2 or acts indirectly not resolved
   • Relevance to human age-related aneuploidy not tested
   • Whether cohesin protection and retrotransposon suppression are coordinated or independent functions unknown
9. 2023 Medium

   Identification of FOXA1 as a direct transcriptional activator of TEX19 in lung adenocarcinoma extended TEX19's relevance beyond the germline, showing that ectopic TEX19 expression promotes glycolysis and proliferation in somatic cancer cells.

   Evidence ChIP for FOXA1 at TEX19 promoter, dual luciferase reporter, Seahorse metabolic flux assay, rescue experiments in lung adenocarcinoma cell lines

   PMID:37606876

   Open questions at the time

   • Downstream mechanism by which TEX19 promotes glycolysis not identified
   • Single-lab finding in cancer cell lines without in vivo validation
10. 2024 Medium

    TEX19 was shown to stabilize CDK4 protein in breast cancer cells by interfering with SKP2-mediated ubiquitination, revealing a cancer-context mechanism of cell cycle promotion distinct from its germline UBR2-dependent functions.

    Evidence Co-IP of TEX19 with CDK4, CHX chase, siRNA knockdown and SKP2 overexpression epistasis, xenograft model

    PMID:38867223

    Open questions at the time

    • Whether TEX19 directly competes with SKP2 for CDK4 binding or acts indirectly not established
    • Relevance to normal germline CDK4 regulation unknown
    • Single-lab study

• How TEX19 coordinates its dual roles in retrotransposon suppression (via L1-ORF1p degradation and piRNA pathway) and meiotic chromosome maintenance (via cohesin protection), and whether these functions are separable or mechanistically linked, remains unresolved.
• No structure of TEX19.1 or TEX19.1–UBR2 complex available
• Whether human TEX19 performs equivalent functions in human germ cells is untested
• Separation-of-function mutations distinguishing transposon suppression from cohesin protection have not been generated